FGFR signaling maintains a drug persistent cell population following epithelial-mesenchymal transition

SUPPLEMENTARY FIGURES AND TABLES Supplementary
: Primary resistance to Lapatinib facilitates secondary resistance to Afatinib. A. HMLE cells stably expressing Her2 or YFP as a control were analyzed for cell surface expression of CD44 and CD24 by flow cytometry. Her2 expressing HMLE cells were treated with TGF-β for 4 weeks and subsequently allowed to recover in the absence of exogenous TGF-β for additional 4 weeks. The CD44 hi expressing cells from this population were isolated via FACS. B. HMLE-Her2 cells were treated with the covalent pan-ErbB inhibitor Afatinib (1 μM) for 4 weeks and surviving mesenchymal cells could be observed but these cells never proliferated into a viable culture, even after removal of Afatinib. C. Three independent Lapatinib resistant cultures were analyzed by immunoblot for expression of Her2, E-cadherin (Ecad) and Vimentin (Vim). Actin served as a loading control. D. Parental, Her2 transformed HMLE cells (Par) and their Lapatinib resistant counterparts (LAPR) were treated with the indicated concentrations of Afatinib or the covalent FGFR inhibitors (FIIN2, FIIN4) for 48 hours and subsequently assessed for cell viability. Data are normalized to untreated cells set to 100% (indicated by the horizontal line) and are the mean ± SD of three independent experiments completed in triplicate resulting in the indicated P values. Figure S2 : Upregulation of the FGFR1-iiic-β isoform predominates drug-induced, TGF-β-induced and Twist-induced EMT events. A. Parental, post-TGF-β and Lapatinib resistant (LapR) Her2 transformed HMLE cells were analyzed by RT-PCR for inclusion of the -iiib or -iiic exon, which encode differential ligand binding domains. These cells were also analyzed for inclusion (α) or exclusion (β) of the third exon, which encodes the outermost Ig domain of these FGFR receptors. The sequences of these primer sets are listed in the Supplemental Table S2 . B. Similar analyses were performed on the Her2-transformed post-TGF-β treated cells that were sorted by FACS based their expression levels of CD44 or CD24. In all cases GAPDH served as a loading control. Supplementary Table S2: The above table lists 
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